| Legal status | |
|---|---|
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Provide&page2=PDM-35 (verify) | |
2-Phenyl-3,5-dimethylmorpholine is a drug with stimulant and anorectic effects, related to phenmetrazine. Based on what is known from other phenylmorpholines with similar structure, it likely acts as a norepinephrine-dopamine releasing agent and may produce effects similar or slightly different to phenmetrazine.1
See also
See also
- 3-Fluorophenmetrazine
- G-130 (2-Phenyl-5,5-dimethylmorpholine)
- 3,4-Phendimetrazine (2-Phenyl-3,4-dimethylmorpholine)
- 3,6-Phendimetrazine (2-Phenyl-3,6-dimethylmorpholine)
- 4-Methylphenmetrazine
- Manifaxine
- Radafaxine
- Viloxazine
References
References
- HU 219458, Boswell GE, Kelley JL, Mehta NB, "2-phenyl-3,5-dimethyl morpholine derivatives, pharmaceutical compositions containing them as active agent and process for preparing them.", published 28 April 2001, assigned to Wellcome Foundation Ltd.